Bayer obtains United States patent.
Bayer Aktiensegellschaft (Leverkusen, Germany) have patented
reagents that regulate human transmembrane serine protease activity and
reagents that bind to human transmembrane serine protease gene . . .
Takara Bio obtains United States patent.
Takara Bio, Inc. (Shiga, Japan) has patented hyperthermostable
proteases having an amino acid sequences represented by SEQ ID Nos. 1, 3
and 5 of the Sequence Listing or functional equivalents . . .
du Pont obtains United States patent.
E.I. du Pont de Nemours and Company (Wilmington, DE) and Cold
Spring Harbor Laboratory (Cold Spring Harbor, NY) have patented a method
for isolating and characterizing a maize gene, RAMOSA3, . . .
Sanofi Pasteur obtains United States patent.
Sanofi Pasteur Limited (Toronto, Ontario, Canada) has patented a
method of nucleic acid, including DNA, immunization of a host, including
humans, against disease caused by infection by a strain of . . .
Max-Planck obtains United States patent.
Max-Planck-Gesellschaft zur Forderung der Wissenschaften, E.V.
(Berlin, Germany) has patented a human K.sup.+ ion channel, to nucleic
acid molecules encoding the same and to vectors comprising said . . .
University of Pennsylvania obtains United States patent.
University of Pennsylvania (Philadelphia, PA) has patented anticode
oligomers and methods of using them for controlling the growth of cancer
cells expressing the bcl-2 gene. (US . . .
Midwest Oilseeds obtains United States patent.
Midwest Oilseeds, Inc. (Adel, IA) has patented a method for the
introduction of molecules, including nucleic acids, carbohydrates, plant
growth regulators and peptides into cells and tissues. The . . .
Stichting Scheikundig Onderzoek In Nederland obtains United
States patent.
Stichting Scheikundig Onderzoek In Nederland (The Hague,
Netherlands) has patented a method for producing oligosaccharides,
comprising selecting a gene which codes for an enzyme which is capable
of . . .
Monsanto obtains United States patent.
Monsanto Technology, LLC (St. Louis, MO) has patented recombinant
constructs and methods useful for improvement of plants. In particular,
recombinant constructs comprising promoters functional in . . .
Pioneer Hi-Bred International obtains United States
patent.
Pioneer Hi-Bred International, Inc. (Johnston, IA) has patented a
novel inbred maize line designated PHEHR and seed, plants and plant
parts thereof. Methods for producing a maize plant that . . .
HER2 homodimer and HER2 total protein assays validated.
Monogram Biosciences, Inc. (South San Francisco, CA) presented the
results of a study detailing the HERmark Assay's ability to
identify metastatic breast cancer patients who are most likely . . .
FMC and Pronova BioPharma agree to develop alginate-based capsule
products.
FMC Corporation (Philadelphia, PA) and Pronova BioPharma ASA
(Norway) have entered into a worldwide license and development agreement
to develop products using a novel capsule technology developed . . .
Cyberonics licenses obesity-related patents.
Cyberonics, Inc. (Houston, TX) entered into an agreement with
Ethicon Endo-Surgery granting exclusive rights to the company's
patents and patent applications pertaining to vagus nerve . . .
DermTech issued patent for early detection, staging and
monitoring of melanoma.
DermTech, Inc. (La Jolla, CA) has been issued United States Patent
7,297,480 by the United States Patent and Trademark Office. The patent,
entitled: "Method for Detection of Melanoma", includes . . .
Cyberonics acquires stroke/brain injury patent rights.
Cyberonics, Inc. (Houston, TX) has acquired the exclusive rights to
three additional patents pertaining to Vagus Nerve Stimulation (VNS) for
the treatment of stroke and traumatic brain injury . . .
Emmaus enters into sub-license agreement for treatment of short
bowel syndrome.
Emmaus Medical, Inc. (Torrance, CA) has entered into an exclusive
sublicense agreement with Cato BioVentures (Research Triangle Park, NC)
for the patent-protected drug NutreStore brand L-Glutamine. . . .
Lonza withdraws majority of claims in patent lawsuit against
Northwest Biotherapeutics.
Northwest Biotherapeutics, Inc. (Bethesda, MD) announced that Lonza
Group AG has withdrawn all claims of patent infringement involving
NWBT's DCVax-Brain product and other NWBT DCVax products other . . .
Athersys and Angiotech announce authorization of Phase I
intramyocardial stem cell United States clinical trial in acute
myocard
Athersys, Inc. (Cleveland, OH) and Angiotech Pharmaceuticals, Inc.
(Vancouver, Canada), said that Athersys has received authorization from
the United States Food and Drug Administration to begin a . . .
Human Genome Sciences and Aegera announce licensing and
collaboration agreement on anti-cancer drugs.
Human Genome Sciences, Inc. (Rockville, MD) and Aegera
Therapeutics, Inc. (Montreal, Canada) said that HGS has acquired
exclusive worldwide rights (excluding Japan) to develop and
commercialize . . .
Cell Genesys announces sale of Lentiviral gene delivery
technology for $12 million.
Cell Genesys, Inc. (S. San Francisco, CA) and GBP IP, LLC
(Greenwich, CT), an affiliate of GBP Capital, the majority shareholder
in privately held Lentigen Corporation, have entered into an asset . . .
|
|